The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series

Curēus
Satish TadepalliVinod Nookala

Abstract

An outbreak of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection started in December 2019 in China that resulted in a global health emergency. The World Health Organization later named the disease as coronavirus disease 2019 (COVID-19). Currently, there is no effective treatment available and the data are evolving through continuous clinical trials and ongoing research. Severe infections present with hypoxemic respiratory failure from acute respiratory distress syndrome as one of the major complications. We report two cases of COVID-19 patients who initially presented with moderate to severe symptoms. Later, their clinical course worsened despite ongoing treatment with multiple medications such as hydroxychloroquine and azithromycin until they were started on tocilizumab. Within a short period after they were administered tocilizumab, their oxygen saturation improved and other inflammatory markers such as D-dimer levels, lactate dehydrogenase, and ferritin levels decreased. There is an increase in the amount of research citing the role of various cytokines in the pathophysiology of COVID-19. Targeting the inflammatory mediators in the pathogenesis, especially interleukin-6 pathway inhibitors, would...Continue Reading

References

Jan 13, 2010·MAbs·Adith Venkiteshwaran
Oct 1, 2010·Therapeutic Advances in Musculoskeletal Disease·Srinivasan Srirangan, Ernest H Choy
Dec 12, 2012·Therapeutic Advances in Musculoskeletal Disease·Shumpei YokotaTadamitsu Kishimoto
May 20, 2014·Annals of the Rheumatic Diseases·Hermine I BrunnerUNKNOWN Pediatric Rheumatology Collaborative Study Group (PRCSG)
Feb 23, 2020·The Lancet. Respiratory Medicine·Zhe XuFu-Sheng Wang
Mar 13, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chuan QinDai-Shi Tian
Mar 20, 2020·Cell & Bioscience·Kit-San YuenDong-Yan Jin
Mar 21, 2020·Lancet·Puja MehtaUNKNOWN HLH Across Speciality Collaboration, UK
Mar 29, 2020·JAMA : the Journal of the American Medical Association·Chenguang ShenLei Liu
Apr 8, 2020·Journal of Medical Virology·Pan LuoJuan Li

❮ Previous
Next ❯

Citations

Jun 3, 2021·Pharmaceuticals·Ashli M HeustessPius S Fasinu

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

European Review for Medical and Pharmacological Sciences
L WangF-C Zhou
Archives of Medical Science : AMS
Nicola Lucio LiberatoGiuseppe Caravella
© 2021 Meta ULC. All rights reserved